Literature DB >> 22044960

Hypercoagulability in congenital haemolytic anaemias.

Massimo Franchini1, Pier Mannuccio Mannucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22044960      PMCID： PMC3496237          DOI： 10.2450/2011.0031-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  47 in total

1.  Advances in iron chelating therapy.

Authors:  M Franchini; G Gandini; G Aprili
Journal:  Haematologica       Date:  2000-11       Impact factor: 9.941

2.  Thrombophilia in thalassemia major patients: analysis of genetic predisposing factors.

Authors:  A Iolascon; P Giordano; S Storelli; H H Li; B Coppola; A Piga; E Fantola; G Forni; P Cianciulli; S Perrotta; C Magnano; A Maggio; A Mangiagli; M Devoto
Journal:  Haematologica       Date:  2001-10       Impact factor: 9.941

3.  Red cells playing as activated platelets in thalassemia intermedia.

Authors:  P M Mannucci
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

4.  Thrombophilia in sickle cell disease: the red cell connection.

Authors:  B N Setty; A K Rao; M J Stuart
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

Review 5.  Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: A review of the literature.

Authors:  Lisa Charneski; Heather Brennan Congdon
Journal:  Am J Health Syst Pharm       Date:  2010-06-01       Impact factor: 2.637

6.  MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease.

Authors:  L Manfrè; E Giarratano; A Maggio; A Banco; G Vaccaro; R Lagalla
Journal:  AJR Am J Roentgenol       Date:  1999-12       Impact factor: 3.959

7.  Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion.

Authors:  B N Yamaja Setty; Surekha Kulkarni; Marie J Stuart
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

Review 8.  Thalassemia trait and arterial thromboembolic events: a systematic review and a meta-analysis of the literature.

Authors:  F Dentali; E Romualdi; W Ageno; M D Cappellini; P M Mannucci
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

9.  Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.

Authors:  M D Cappellini; L Robbiolo; B M Bottasso; R Coppola; G Fiorelli; A P Mannucci
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

Review 10.  Advances in the use of hydroxyurea.

Authors:  Russell E Ware; Banu Aygun
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009
View more
  3 in total

Review 1.  Thalassemia and Moyamoya syndrome: unfurling an intriguing association.

Authors:  Shambaditya Das; Souvik Dubey; Mrinal Acharya; Subhankar Chatterjee; Durjoy Lahiri; Goutam Das; Biman Kanti Ray; Markus Kraemer
Journal:  J Neurol       Date:  2019-08-17       Impact factor: 4.849

2.  Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients.

Authors:  Suneerat Hatairaktham; Patarabutr Masaratana; Chattree Hantaweepant; Chatchawan Srisawat; Vorapan Sirivatanauksorn; Noppadol Siritanaratkul; Narumol Panichkul; Ruchaneekorn W Kalpravidh
Journal:  Ann Hematol       Date:  2021-01-03       Impact factor: 3.673

3.  ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.

Authors:  Julien Demagny; Aurélie Driss; Alain Stepanian; Nadia Anguel; Louis Affo; Damien Roux; Anoosha Habibi; Sandrine Benghezal; Sophie Capdenat; Paul Coppo; Françoise Driss; Agnès Veyradier
Journal:  Res Pract Thromb Haemost       Date:  2020-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.